Therapeutic potential of 20(S)-ginsenoside Rg3 against streptozotocin-induced diabetic renal damage in rats

Ahmed, 2005, Advanced glycation endproducts—role in pathology of diabetic complications, Diabetes Res. Clin. Pract., 67, 3, 10.1016/j.diabres.2004.09.004 Bankir, 2001, Vasopressin and diabetes mellitus, Nephron, 87, 8, 10.1159/000045879 Baynes, 1991, Role of oxidative stress in development of complications in diabetes, Diabetes, 40, 405, 10.2337/diabetes.40.4.405 Blantz, 2002, The complex role of nitric oxide in the regulation of glomerular ultrafiltration, Kidney Int., 61, 782, 10.1046/j.1523-1755.2002.00220.x Chen, 2005, Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction, Cardiovasc. Diabetol., 4, 3, 10.1186/1475-2840-4-3 Cooper, 2001, Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy, Diabetologia, 44, 1957, 10.1007/s001250100000 Courderot-Masuyer, 1999, Antioxidant properties of aminoguanidine, Fundam. Clin. Pharmacol., 13, 535, 10.1111/j.1472-8206.1999.tb00358.x Daulhac, 2006, Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-d-aspartate-dependent mechanisms, Mol. Pharmacol., 70, 1246, 10.1124/mol.106.025478 de Arriba, 2006, Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity, Free Radic. Biol. Med., 40, 779, 10.1016/j.freeradbiomed.2005.09.038 Deng, 2002, Vasodilatory N-methyl-d-aspartate receptors are constitutively expressed in rat kidney, J. Am. Soc. Nephrol., 13, 1381, 10.1097/01.ASN.0000013293.11876.4E Figarola, 2005, Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors, Diabetes Metab. Res. Rev., 21, 533, 10.1002/dmrr.550 Flückiger, 1976, In vitro synthesis of hemoglobin AIc, FEBS Lett., 71, 356, 10.1016/0014-5793(76)80969-6 Horie, 1997, Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy, J. Clin. Invest., 100, 2995, 10.1172/JCI119853 Itzhaki, 1964, A micro-biuret method for estimating proteins, Anal. Biochem., 9, 401, 10.1016/0003-2697(64)90200-3 Kang, 2006, Protective effect of sun ginseng against diabetic renal damage, Biol. Pharm. Bull., 29, 1678, 10.1248/bpb.29.1678 Kang, 2006, Stereospecificity in hydroxyl radical scavenging activities of four ginsenosides produced by heat processing, Bioorg. Med. Chem. Lett., 16, 5028, 10.1016/j.bmcl.2006.07.071 Kang, 2007, Study on the hydroxyl radical scavenging activity changes of ginseng and ginsenoside-Rb2 by heat processing, Biol. Pharm. Bull., 30, 724, 10.1248/bpb.30.724 Kang, 2007, ESR study on the structure and hydroxyl radical-scavenging activity relationships of ginsenosides isolated from Panax ginseng C. A. Meyer, Biol. Pharm. Bull., 30, 917, 10.1248/bpb.30.917 Kedziora-Kornatowska, 1998, Effect of aminoguanidine on lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney, Biochem. Mol. Biol. Int., 46, 577 Keum, 2003, Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion, Mutat. Res., 523–524, 75, 10.1016/S0027-5107(02)00323-8 Kim, 2007, Protective effect of heat-processed American ginseng against diabetic renal damage, J. Agric. Food Chem., 55, 8491, 10.1021/jf071770y Kim, 2004, Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons, Biochem. Biophys. Res. Commun., 323, 416, 10.1016/j.bbrc.2004.08.106 Leung, 2002, Expression and developmental regulation of the NMDA receptor subunits in the kidney and cardiovascular system, Am. J. Physiol. Regul. Integr. Comp. Physiol., 283, R964, 10.1152/ajpregu.00629.2001 Leung, 2004, Altered NMDA receptor expression in renal toxicity: protection with a receptor antagonist, Kidney Int., 66, 167, 10.1111/j.1523-1755.2004.00718.x Levin, 2001, Identification of patients and risk factors in chronic kidney disease-evaluating risk factors and therapeutic strategies, Nephrol. Dial. Transplant., 16, 57, 10.1093/ndt/16.suppl_7.57 Mihara, 1978, Determination of malonaldehyde precursor in tissues by thiobarbituric acid test, Anal. Biochem., 86, 271, 10.1016/0003-2697(78)90342-1 Nagai, 2002, Peroxynitrite induces formation of Nε-(carboxymethyl)lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose. Novel pathways for protein modification by peroxynitrite, Diabetes, 51, 2833, 10.2337/diabetes.51.9.2833 Naito, 1978, Lipid peroxides in atherosclerotic diseases, Nippon Ronen Igakkai Zasshi, 15, 187 Nakayama, 1993, Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin-induced diabetic rat, Diabetes, 42, 345, 10.2337/diabetes.42.2.345 Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage, Nature, 404, 787, 10.1038/35008121 Notenboom, 2002, Role of NO in endohelin-regulated drug transport in the renal proximal tubule, Am. J. Physiol. Renal Physiol., 282, F458, 10.1152/ajprenal.00173.2001 Park, 1998, A new processed ginseng with fortified activity, 146 Price, 2001, Chelating activity of advanced glycation end-products inhibitors, J. Biol. Chem., 276, 48967, 10.1074/jbc.M108196200 Rangan, 1999, Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats, Kidney Int., 56, 118, 10.1046/j.1523-1755.1999.00529.x Schrijvers, 2004, From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines, Endocr. Rev., 25, 971, 10.1210/er.2003-0018 Soulis-Liparota, 1991, Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat, Diabetes, 40, 1328, 10.2337/diabetes.40.10.1328 Surh, 2001, Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation, Mutat. Res., 480–481, 243, 10.1016/S0027-5107(01)00183-X Surh, 2001, Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A. Meyer, J. Korean Med. Sci., 16, S38, 10.3346/jkms.2001.16.S.S38 The Diabetes Control and Complications Trial Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med., 329, 977, 10.1056/NEJM199309303291401 Turk, 2002, Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus, Acta Diabetol., 39, 117, 10.1007/s005920200029 Tuttle, 2005, Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C, Kidney Int., 67, 953, 10.1111/j.1523-1755.2005.00159.x Virág, 2003, Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention, Toxicol. Lett., 140–141, 113, 10.1016/S0378-4274(02)00508-8 Vlassara, 1994, Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats, Proc. Natl. Acad. Sci. USA, 91, 11704, 10.1073/pnas.91.24.11704 Warne, 2006, Comparison of superior mesenteric versus jugular venous infusions of insulin in streptozotocin-diabetic rats on the choice of caloric intake, body weight, and fat stores, Endocrinology, 147, 5443, 10.1210/en.2006-0702 Wendt, 2003, Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy, J. Am. Soc. Nephrol., 14, 1383, 10.1097/01.ASN.0000065100.17349.CA Williams, 2003, New therapies for advanced glycation end product nephrotoxicity: current challenges, Am. J. Kidney Dis., 41, S42, 10.1053/ajkd.2003.50083 Yamabe, 2007, Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats, Biol. Pharm. Bull., 30, 520, 10.1248/bpb.30.520 Y an, 1994, Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J. Biol. Chem., 269, 9889, 10.1016/S0021-9258(17)36966-1 Yokozawa, 2004, A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats, Nephron Exp. Nephrol., 97, 38, 10.1159/000078405